Adenovirus-mediated specific tumor tagging facilitates CAR-T therapy against antigen-mismatched solid tumors.
第一作者:
Xinying,Tang
第一单位:
Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, 211198, PR China.
作者:
主题词
腺病毒科(Adenoviridae);动物(Animals);抗原, CD19(Antigens, CD19);抗原, 肿瘤(Antigens, Neoplasm);细胞系, 肿瘤(Cell Line, Tumor);综合疗法(Combined Modality Therapy);人类(Humans);免疫突触(Immunological Synapses);免疫疗法, 过继(Immunotherapy, Adoptive);小鼠(Mice);溶瘤病毒疗法(Oncolytic Virotherapy);溶瘤病毒(Oncolytic Viruses);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);T淋巴细胞(T-Lymphocytes);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1016/j.canlet.2020.05.013
PMID
32454143
发布时间
2021-01-12
- 浏览0
Cancer letters
1-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文